Меню
Набор скоро начнётся NCT07620132

Mechanical Power for Ventilatory Settings in Operating Room

Без фазы С лечением Postoperative Respiratory Failure Abdominal Surgery Postoperative Pulmonary Complications Morality

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Mechanical power-guided ventilatory strategy, Standard fixed ventilatory settings.
Кому может быть актуально
Состояния в реестре: Postoperative Respiratory Failure, Abdominal Surgery, Postoperative Pulmonary Complications, Morality. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Список центров уточняется — проверьте первичный протокол.
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Mechanical Power for Ventilatory Settings in Operating Room: a Multicenter Randomized Controlled Trial

Обзор

Postoperative respiratory failure (PRF) is a dreaded complication that imposes a significant burden through unplanned admission to the ICU, post discharge disability and mortality. Despite widespread implementation of intraoperative lung-protective ventilation strategies over the past decade, results remain inconsistent. Interventions targeting individual parameters like tidal volume or positive end-expiratory pressure (PEEP) have shown equivocal results. The use of high PEEP and recruitment maneuvers raises safety concerns by possible negative hemodynamic effects. Recent studies suggest that individualizing ventilation strategies based on mechanical power-a composite parameter integrating tidal volume, plateau pressure, PEEP, and ventilator frequency-may better predict and help prevent PRF, independently of patients' baseline respiratory system compliance. These studies identified this parameter as interventional targets to reduce lung injury during mechanical ventilation. However, no multicenter randomized controlled trial has been performed in the field of ventilatory settings titration during invasive mechanical ventilation in operating room. The investigators hypothesize that a ventilation strategy aimed at decreasing mechanical power will reduce the incidence of PRF and mortality in patients undergoing abdominal surgery, compared with a standard strategy using fixed tidal volume and PEEP

Подробное описание

Postoperative respiratory failure (PRF) is a dreaded complication that imposes a significant burden through unplanned admission to the intensive care unit (ICU) and post discharge disability. Respiratory failure evident by tracheal intubations 1 month following nonemergent, noncardiac surgeries has been associated with a nine-fold increase in mortality. Efforts to reduce the rates of PRF have incorporated intraoperative ventilation strategies as a central element, with lung-protective ventilation following recommendations for the ICU setting being broadly implemented over the past decade. Interventions targeting individual parameters like tidal volume have shown equivocal results. To summarize, two randomized clinical trials showed lung-protective ventilation with low tidal volume (VT) in addition to high positive end-expiratory pressure (PEEP) and recruitment maneuver (RM) to prevent against postoperative pulmonary complications when compared with ventilation with high VT plus low PEEP without RM. Two other large, randomized trials found no benefit of high PEEP with RM compared with low PEEP without RM in this setting, suggesting that beneficial effects arise primarily from the use of low VT ventilation. Concerns have also been raised about possible negative hemodynamic effects of high PEEP and RMs in these studies. One size does not fit all. Individualized strategies are needed, such as ones using driving pressure (plateau pressure - PEEP), to perform PEEP titration. Using this calculated parameter, reduced incidence of postoperative pulmonary complications has been demonstrated in small randomized controlled trials, and not achieved in others. However, tidal volume and respiratory rate are also important parameters to limit ventilator induced injuries, and are not considered when assessing driving pressure. Mechanical power, a concept that in addition to tidal volume, plateau pressure and positive end-expiratory pressure (PEEP) also integrates the ventilatory frequency, has been recently associated with a higher risk of PRF. This formula is now implemented in the most recent operating room ventilators, and used in routine by some teams, with lack of evidence showing an efficacy of this strategy to set ventilatory settings. Although it has become clear that high mechanical power identifies patients at risk of PRF both in the operating room and ICU, there is an ongoing debate about whether they are linked to PRF, or whether these parameters merely represent an epiphenomenon in patients with impaired respiratory system mechanics and elevated risk at baseline.

Recently, several studies showed that high mechanical power was associated with PRF independent from patients' baseline respiratory system compliance. These studies identified this parameter as interventional targets to reduce lung injury during mechanical ventilation. However, no multicenter randomized controlled trial has been performed in the field of ventilatory settings titration during invasive mechanical ventilation in operating room.

The investigators made the hypothesis that a strategy aimed at decreasing mechanical power (tidal volume, respiratory rate and PEEP individually titrated to minimize the mechanical power) will reduce PRF and mortality in patients undergoing abdominal surgery, when compared with that of a strategy of standard care (with fixed level of tidal volume and PEEP). The investigators expect decreased PRF and mortality rate in the group "mechanical power-guided ventilatory settings". The investigators also expect in this group reduced duration of postoperative mechanical ventilation, reduced incidence of postoperative organ dysfunction, and reduced duration of hospital stay.

Вмешательства

  • Процедура Mechanical power-guided ventilatory strategy
    1. Tidal volume 7ml/kg PBW and RR titrated for EtCO2 between 40-50mmHg. See calculated Mechanical power:0,049\*tidal volume\*RR\*driving pressure. 2. Set PEEP 15cmH2O and perform recruitment maneuver at 30cmH2O for 20s. Decrease PEEP from 15 by steps of 2cmH2O until the lower level of PEEP minimizing mechanical power. Note mechanical power. Stop maneuver and/or decrease level of PEEP if decrease\>20% of cardiac output during the maneuver, when compared to baseline. 3. Repeat this step using 9 ml
  • Процедура Standard fixed ventilatory settings
    Tidal volume 7 ml/kg predicted body weight, calculated according to a predefined formula: 50+0.91 x (centimeters of height - 152.4) for males and 45.5+0.91 x (centimeters of height - 152.4) for females, fixed PEEP between 6 and 8 cmH20, recruitment maneuvers at the discretion of the physician. The respiratory rate will be adjusted to maintain end-tidal partial pressure of CO2 between 30 and 40 mmHg, a target reported to be used by approximately 90% of physicians according to a recent online sur

Первичные конечные точки

  • Composite of postoperative respiratory failure [Срок оценки: Up to 12 hours after surgery]
  • Composite of postoperative respiratory failure [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
  • Composite of postoperative respiratory failure [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
  • All-cause mortality [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
Вторичные конечные точки (12)
  • Severity of postoperative pulmonary complications following surgery [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
  • Renal dysfunction following surgery [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
  • Sepsis and septic shock following surgery [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
  • Sepsis-related Organ Failure Assessment (SOFA) [Срок оценки: At randomization (day 0), at Day 1, at Day 7]
  • Ventilator-free days (VFDs) [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
  • Duration of invasive mechanical ventilation [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
  • Total duration of mechanical ventilation [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
  • Time to successful tracheal extubation [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
  • ICU-free days [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
  • Length of ICU stay [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
  • Length of hospital stay [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]
  • Time to death (or censoring) [Срок оценки: Up to 30 days after surgery, or by the date of hospital discharge, if this occurs before Day 30]

Критерии участия

Критерии включения

  • Adult (≥ 18 years)
  • Laparoscopic or non-laparoscopic abdominal surgery
  • With an expected duration of at least 2 hours

Критерии исключения

  • Patients already receiving mechanical ventilation > 12 hours before surgery;
  • Chronic respiratory disease requiring oxygen therapy or mechanical ventilation at home;
  • Undrained pneumothorax or subcutaneous emphysema;
  • Intracranial hypertension;
  • Patients for which death is deemed imminent and inevitable or patients with an underlying disease process with a life expectancy of less than 3 months;
  • Patients already enrolled in the IMPROVE III trial;
  • Pregnancy in progress or planned during the study period or breastfeeding women (Art. L1121-5 of the French Public Health Code);
  • Patients protected by law (Art. L1121-6 to L1121-8 of the French Public Health Code): Individuals deprived of their liberty by judicial or administrative decision, vulnerable persons, minors, adults under guardianship or curatorship;
  • Patients not covered by a French social security scheme and not benefiting from such a scheme;
  • Absence of free and informed oral consent from the patient before inclusion (except in emergency situation where the patient is unable to provide consent), or absence of written informed consent from his/her proxy if present in an emergency situation (except in life-threatening emergency, where inclusion without consent from the patient or his/her proxy is permitted), in which case consent will be obtained as soon as possible after inclusion.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Двойное слепое
Основная цель
Лечение

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Идентификаторы

NCT: NCT07620132 · RECHMPL24_0492

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗